Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trine Kvist

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Expert Opinion on Drug Discovery|June 1, 2012
The use of Xenopus oocytes in drug screeningTrine Kvist, Kasper Bø Hansen, Hans Bräuner-Osborne
Combinatorial Chemistry & High Throughput Screening|March 12, 2009
The four human gamma-aminobutyric acid (GABA) transporters: pharmacological characterization and validation of a highly efficient screening assayTrine Kvist, Bolette Christiansen, Anders A Jensen, et al.
The AAPS Journal|October 14, 2025
Patient-Centric Drug Product Quality Specifications: a Convergence of Clinical and Nonclinical ConsiderationsStan Altan, Hans Coppenolle, Trine Kvist, et al.
Neuropharmacology|August 27, 2013
Structure-based discovery of antagonists for GluN3-containing N-methyl-D-aspartate receptorsTrine Kvist, Jeremy R Greenwood, Kasper B Hansen, et al.
Diabetes, Obesity & Metabolism|September 24, 2017
Semaglutide improves postprandial glucose and lipid metabolism, and delays first-hour gastric emptying in subjects with obesityJulie B Hjerpsted, Anne Flint, Ashley Brooks, et al.
Diabetes, Obesity & Metabolism|March 8, 2017
Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesityJohn Blundell, Graham Finlayson, Mads Axelsen, et al.
Biochemical Pharmacology|June 25, 2013
Discovery of a subtype selective inhibitor of the human betaine/GABA transporter 1 (BGT-1) with a non-competitive pharmacological profileBolette Kragholm, Trine Kvist, Karsten K Madsen, et al.
The Journal of Biological Chemistry|September 28, 2013
Crystal structure and pharmacological characterization of a novel N-methyl-D-aspartate (NMDA) receptor antagonist at the GluN1 glycine binding siteTrine Kvist, Thomas Bielefeldt Steffensen, Jeremy R Greenwood, et al.
Molecular Pharmacology|December 15, 2015
Pharmacology and Structural Analysis of Ligand Binding to the Orthosteric Site of Glutamate-Like GluD2 ReceptorsAnders S Kristensen, Kasper B Hansen, Peter Naur, et al.
Bioorganic & Medicinal Chemistry|July 20, 2010
A new metabotropic glutamate receptor agonist with in vivo anti-allodynic activityNathan J Stanley, Mark R Hutchinson, Trine Kvist, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Expert Opinion on Drug Discovery|June 1, 2012
The use of Xenopus oocytes in drug screeningTrine Kvist, Kasper Bø Hansen, Hans Bräuner-Osborne
Combinatorial Chemistry & High Throughput Screening|March 12, 2009
The four human gamma-aminobutyric acid (GABA) transporters: pharmacological characterization and validation of a highly efficient screening assayTrine Kvist, Bolette Christiansen, Anders A Jensen, et al.
The AAPS Journal|October 14, 2025
Patient-Centric Drug Product Quality Specifications: a Convergence of Clinical and Nonclinical ConsiderationsStan Altan, Hans Coppenolle, Trine Kvist, et al.
Neuropharmacology|August 27, 2013
Structure-based discovery of antagonists for GluN3-containing N-methyl-D-aspartate receptorsTrine Kvist, Jeremy R Greenwood, Kasper B Hansen, et al.
Diabetes, Obesity & Metabolism|September 24, 2017
Semaglutide improves postprandial glucose and lipid metabolism, and delays first-hour gastric emptying in subjects with obesityJulie B Hjerpsted, Anne Flint, Ashley Brooks, et al.
Diabetes, Obesity & Metabolism|March 8, 2017
Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesityJohn Blundell, Graham Finlayson, Mads Axelsen, et al.
Biochemical Pharmacology|June 25, 2013
Discovery of a subtype selective inhibitor of the human betaine/GABA transporter 1 (BGT-1) with a non-competitive pharmacological profileBolette Kragholm, Trine Kvist, Karsten K Madsen, et al.
The Journal of Biological Chemistry|September 28, 2013
Crystal structure and pharmacological characterization of a novel N-methyl-D-aspartate (NMDA) receptor antagonist at the GluN1 glycine binding siteTrine Kvist, Thomas Bielefeldt Steffensen, Jeremy R Greenwood, et al.
Molecular Pharmacology|December 15, 2015
Pharmacology and Structural Analysis of Ligand Binding to the Orthosteric Site of Glutamate-Like GluD2 ReceptorsAnders S Kristensen, Kasper B Hansen, Peter Naur, et al.
Bioorganic & Medicinal Chemistry|July 20, 2010
A new metabotropic glutamate receptor agonist with in vivo anti-allodynic activityNathan J Stanley, Mark R Hutchinson, Trine Kvist, et al.
Pageof 2